JP1691601S - - Google Patents

Info

Publication number
JP1691601S
JP1691601S JPD2020-21954F JP2020021954F JP1691601S JP 1691601 S JP1691601 S JP 1691601S JP 2020021954 F JP2020021954 F JP 2020021954F JP 1691601 S JP1691601 S JP 1691601S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-21954F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2020-21954F priority Critical patent/JP1691601S/ja
Priority to TW110301815F priority patent/TWD216751S/zh
Application granted granted Critical
Publication of JP1691601S publication Critical patent/JP1691601S/ja
Priority to US29/891,312 priority patent/USD1069158S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-21954F 2020-10-13 2020-10-13 Active JP1691601S (enExample)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JPD2020-21954F JP1691601S (enExample) 2020-10-13 2020-10-13
TW110301815F TWD216751S (zh) 2020-10-13 2021-04-12 細胞培養袋
US29/891,312 USD1069158S1 (en) 2020-10-13 2023-05-04 Cell culture bag

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2020-21954F JP1691601S (enExample) 2020-10-13 2020-10-13

Publications (1)

Publication Number Publication Date
JP1691601S true JP1691601S (enExample) 2021-08-02

Family

ID=77057810

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2020-21954F Active JP1691601S (enExample) 2020-10-13 2020-10-13

Country Status (2)

Country Link
JP (1) JP1691601S (enExample)
TW (1) TWD216751S (enExample)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP1586945S (enExample) 2017-03-31 2020-09-28

Also Published As

Publication number Publication date
TWD216751S (zh) 2022-01-21

Similar Documents

Publication Publication Date Title
JP1680565S (enExample)
JP1687139S (enExample)
JP1687242S (enExample)
JP1691598S (enExample)
JP1680566S (enExample)
JP1680567S (enExample)
BR102021007058A2 (enExample)
BR102020022030A2 (enExample)
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134275A1 (es) Anticuerpos cd24
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134206A1 (es) Degradantes y usos de los mismos
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)